Micromatrices Associates Ltd
MicroMatrices, founded in 2011 and based in Dundee, Scotland, is a life sciences company specializing in unlocking molecular and phenotypic information from tissue samples using integrated toxicology, histology, transcriptomic, and proteomic technologies. Their patented SpheroMatrices® microTMA technology enables medium-high throughput histological analysis of 3D spheroid/organoid cultures, facilitating drug target visualization, safety assessment, mode of action studies, and biomarker discovery. The company serves pharmaceutical, agribusiness, and chemical industries with scalable, efficient, and flexible molecular phenotyping platforms. MicroMatrices collaborates interactively with clients, supporting early discovery, development, and product lifecycle maintenance, and integrates AI and bioinformatics tools to enhance translational research. Their technology and services are recognized for innovation and are supported by a strong scientific core network and partnerships with facilities of excellence.
Micromatrices Associates Ltd
MicroMatrices, founded in 2011 and based in Dundee, Scotland, is a life sciences company specializing in unlocking molecular and phenotypic information from tissue samples using integrated toxicology, histology, transcriptomic, and proteomic technologies. Their patented SpheroMatrices® microTMA technology enables medium-high throughput histological analysis of 3D spheroid/organoid cultures, facilitating drug target visualization, safety assessment, mode of action studies, and biomarker discovery. The company serves pharmaceutical, agribusiness, and chemical industries with scalable, efficient, and flexible molecular phenotyping platforms. MicroMatrices collaborates interactively with clients, supporting early discovery, development, and product lifecycle maintenance, and integrates AI and bioinformatics tools to enhance translational research. Their technology and services are recognized for innovation and are supported by a strong scientific core network and partnerships with facilities of excellence.